Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Individualization of therapy based on a person’s specific type of diabetes is one key element of a “precision medicine” approach to diabetes care. However, applying such an approach remains difficult because of barriers such as disease heterogeneity, difficulties in accurately diagnosing different types of diabetes, multiple genetic influences, incomplete understanding of pathophysiology, limitations of current therapies, and environmental, social, and psychological factors. Monogenic diabetes, for which single gene mutations are causal, is the category most suited to a precision approach. The pathophysiological mechanisms of monogenic diabetes are understood better than those of any other form of diabetes. Thus, this category offers the advantage of accurate diagnosis of nonoverlapping etiological subgroups for which specific interventions can be applied. Although representing a small proportion of all diabetes cases, monogenic forms present an opportunity to demonstrate the feasibility of precision medicine strategies. In June 2019, the editors of Diabetes Care convened a panel of experts to discuss this opportunity. This article summarizes the major themes that arose at that forum. It presents an overview of the common causes of monogenic diabetes, describes some challenges in identifying and treating these disorders, and reports experience with various approaches to screening, diagnosis, and management. This article complements a larger American Diabetes Association effort supporting implementation of precision medicine for monogenic diabetes, which could serve as a platform for a broader initiative to apply more precise tactics to treating the more common forms of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Monogenic defects that cause b -cell dysfunction, such as neonatal diabetes and MODY, are present in a small fraction of people with diabetes ( < 5%) (155).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [155]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Self-citationLifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationMutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 976
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Self-citation
Cited by
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05181-w · Cited by 203
Self-citationBonnefond, A., Unnikrishnan, R., Doria, A., Vaxillaire, M., Kulkarni, R., Mohan, V., Trischitta, V., & Froguel, P. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00421-w · Cited by 190
Personalized type 2 diabetes management: an update on recent advances and recommendations
Williams, D. M., Jones, H., & Stephens, J. W. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s331654 · Cited by 121
Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)
Tosur, M., & Philipson, L. H. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13860 · Cited by 111
Self-citationTowards a better understanding of diabetes mellitus using organoid models
Beydag-Tasöz, B. S., Yennek, S., & Grapin‐Botton, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00797-x · Cited by 95
Varney, M. J., & Benovic, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001015 · Cited by 90
Saint‐Martin, C., Bouvet, D., Bastide, M., & Bellanné‐Chantelot, C. (2021) · Diabetes · doi:10.2337/db21-0520 · Cited by 53
Do gene–environment interactions have implications for the precision prevention of type 2 diabetes?
Sørensen, T. I. A., Metz, S., & Kilpeläinen, T. O. (2022) · Diabetologia · doi:10.1007/s00125-021-05639-5 · Cited by 52
Huerta‐Chagoya, A., Schroeder, P. H., Mandla, R., Li, J., Morris, L., Vora, M., Alkanaq, A. N., Nagy, D., Szczerbiński, Ł., Madsen, J. G. S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01947-9 · Cited by 52
Rocha, S., Lucas, M., Ribeiro, D., Corvo, M. L., Fernandes, E. G. R., & Freitas, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105604 · Cited by 50
Endocrine Manifestations and New Developments in Mitochondrial Disease
Ng, Y. S., Lim, A. Z., Panagiotou, G., Turnbull, D. M., & Walker, M. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab036 · Cited by 48
Precision treatment of beta-cell monogenic diabetes: a systematic review
Naylor, R. N., Patel, K., Kettunen, J. L. T., Männistö, J. M. E., Støy, J., Beltrand, J., Polak, M., PMDI, A., Tobias, D. K., Merino, J., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00556-1 · Cited by 46
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes Care · doi:10.2337/dci21-0051 · Cited by 40
Harsunen, M. H., Kettunen, J. L. T., Härkönen, T., Dwivedi, O. P., Lehtovirta, M., Vähäsalo, P., Veijola, R., Ilonen, J., Miettinen, P. J., Knip, M., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05834-y · Cited by 36
Recessive Genome-Wide Meta-analysis Illuminates Genetic Architecture of Type 2 Diabetes
O’Connor, M. J., Schroeder, P. H., Huerta‐Chagoya, A., Cortés-Sánchez, P., Bonàs‐Guarch, S., Guindo-Martínez, M., Cole, J. B., Kaur, V., Torrents, D., Veerapen, K., et al. (2021) · Diabetes · doi:10.2337/db21-0545 · Cited by 29
Diabetes and obesity: leveraging heterogeneity for precision medicine
Franks, P. W., & Sargent, J. L. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae746 · Cited by 28
Self-citationPassanisi, S., Salzano, G., Bombaci, B., & Lombardo, F. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00716-6 · Cited by 27
Yang, J., Zhen, J., Feng, W., Fan, Z., Ding, L., Yang, X., Huang, Y., Shu, H., Xie, J., Li, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204443119 · Cited by 26
Severe Insulin Resistance Syndromes: Clinical Spectrum and Management
Pliszka, M., & Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125669 · Cited by 23
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes · doi:10.2337/db21-0777 · Cited by 22
Williams, C. L., Aitken, R. J., Wilson, I. V., Mortimer, G., Long, A. E., Williams, A. J. K., The BOX Study Group, & Gillespie, K. M. (2022) · Diabetic Medicine · doi:10.1111/dme.14979 · Cited by 22
Kapellou, A., Salata, E., Vrachnos, D. M., Papailia, S. I., & Vittas, S. (2025) · Genes · doi:10.3390/genes16050578 · Cited by 21
A Novel Quality-Control Procedure to Improve the Accuracy of Rare Variant Calling in SNP Arrays
Sun, T.-H., Shao, Y. J., Mao, C.-L., Hung, M., Lo, Y.-Y., Ko, T., & Hsiao, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.736390 · Cited by 19
Mifsud, F., Saint‐Martin, C., Dubois‐Laforgue, D., Bouvet, D., Timsit, J., & Bellanné‐Chantelot, C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109908 · Cited by 19
Aarthy, R., Aston‐Mourney, K., Amutha, A., Mikocka‐Walus, A. A., Anjana, R. M., Unnikrishnan, R., Jebarani, S., Venkatesan, U., Gopi, S., Radha, V., et al. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.04.004 · Cited by 19
The Spectrum of Genetic Variants Associated with the Development of Monogenic Obesity in Qatar
AbouHashem, N., Zaied, R. E., Al-Shafai, K., Nofal, M., Syed, N., & Al-Shafai, M. N. (2022) · Obesity Facts · doi:10.1159/000521851 · Cited by 19
Monogenic diabetes: An evidence-based clinical approach
Bhattacharya, S., Fernandez, C. J., Kamrul-Hasan, A. B. M., & Pappachan, J. M. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.104787 · Cited by 18
A genomic data archive from the Network for Pancreatic Organ donors with Diabetes
Perry, D. J., Shapiro, M. R., Chamberlain, S. W., Kusmartseva, I., Chamala, S., Balzano‐Nogueira, L., Yang, M., Brant, J. O., Brusko, M., Williams, M. D., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02244-6 · Cited by 16
Pattanaik, S. K., Anil, M., Jena, S., & Rath, D. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998335480241022084655 · Cited by 15
A centennial review of discoveries and advances in diabetes: Children and youth
Mistry, S., Tonyushkina, K. N., Benavides, V. C., Choudhary, A., Huerta‐Saenz, L., Patel, N. S., Mahmud, F. H., Libman, I. M., & Sperling, M. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13392 · Cited by 14
HNF1α maintains pancreatic α and β cell functions in primary human islets
Qian, M. F., Bevacqua, R. J., Nguyen, V. M., Liu, X., Zhao, W., Chang, C., Gu, X., Dai, X.-Q., MacDonald, P. E., & Kim, S. K. (2023) · JCI Insight · doi:10.1172/jci.insight.170884 · Cited by 14
Zhang, H., Kleinberger, J. W., Maloney, K. A., Guan, Y., Mathias, T. J., Bisordi, K., Streeten, E. A., Blessing, K. K., Snyder, M. N., Bromberger, L. A., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1975 · Cited by 13
Chaturvedi, N., Voight, B. F., Wells, J. C. K., & Pritlove, C. (2025) · Diabetologia · doi:10.1007/s00125-025-06516-1 · Cited by 13
Updates of precision medicine in type 2 diabetes
Xia, M., & Li, X. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.12 · Cited by 13
Serbis, A., Kantza, E., Siomou, E. C., Galli‐Τsinopoulou, A., Kanaka‐Gantenbein, C., & Tigas, S. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910501 · Cited by 12
SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY
Suzuki, S., Kokumai, T., Furuya, A., & Takahashi, S. (2023) · Diabetes Care · doi:10.2337/dc22-1573 · Cited by 12
Tsoi, S. T. F., Lim, C. K. P., Ronald, C. W., Lau, E. S. H., Fan, B., Chow, E., Kong, A. P. S., Chan, J. C. N., & Luk, A. O. Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3823 · Cited by 11
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., Rosenblum, N. D., Rosenblum, N. D., Cefalu, W. T., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.09.126 · Cited by 10
Genetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions
Sun, H., & Lin, X.-Y. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1738 · Cited by 10
McCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Monogenic diabetes due to an INSR mutation in a child with severe insulin resistance
Sanderson, E., Shah, M., Hooper, A. J., Bell, D. A., & Choong, C. S. (2022) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0114 · Cited by 9
Classification of type 1 diabetes: A pathogenic and treatment-based classification
Patel, S., Fourlanos, S., & Greenfield, J. R. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102986 · Cited by 9
Next-generation sequencing technologies in diabetes research
Fareed, M., Chauhan, W., Fatma, R., Din, I., Afzal, M., & Ahmed, Z. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100097 · Cited by 9
Diabetes-Associated Mutations in Proinsulin Provide a “Molecular Rheostat” of Nascent Foldability
Dhayalan, B., & Weiss, M. A. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01447-2 · Cited by 8
Steenkamp, D. W., Cheney, M. C., Ju, Z., Rodbard, D., & Wolpert, H. A. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad038 · Cited by 7
Bombonato, M., Beccuti, G., Benso, A. S., Giannone, B., Bertaina, S., Broglio, F., & Bioletto, F. (2025) · HORMONES · doi:10.1007/s42000-025-00632-8 · Cited by 7
Optimizing maturity‐onset diabetes of the young detection in a pediatric diabetes population
Menon, S., REFAEY, A. K., Guffey, D., Balasubramanyam, A., REDONDO, M. J., & Tosur, M. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13329 · Cited by 7
Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes
Zhang, J., Zhang, R., LIU, C., Ge, X., Wang, Y., Jiang, F., Zhuang, L., Li, T., Zhu, Q., Jiang, Y., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06186-5 · Cited by 7
Here’s to 100 Years of Insulin and Science—and More to Come!
Riddle, M. C. (2021) · Diabetes Care · doi:10.2337/dci21-0013 · Cited by 7
Self-citationErukulapati, R. S., Ganguri, M., Menon, A. S., Ayyagari, U., Jayapaul, M. K., Gurazada, K. C., Nalla, S., Srinath, A., Sampath, S. K., Manohar, S. P., et al. (2023) · Clinical Diabetology · doi:10.5603/dk.a2022.0061 · Cited by 6
Alarcon, G., Nguyen, A., Jones, A., Shields, B., Redondo, M. J., & Tosur, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae770 · Cited by 6
Carrera, P., Marzinotto, I., Bonfanti, R., Massimino, L., Calzavara, S., Favellato, Μ., Jofra, T., Giglio, V. D., Bonura, C., Stabilini, A., et al. (2023) · Diabetologia · doi:10.1007/s00125-022-05865-5 · Cited by 6
Review Article: Overview of Clinical Genetics of Diabetes Mellitus
Asamoah, A., & Ahima, R. S. (2026) · Genes · doi:10.3390/genes17020215 · Cited by 6
Further evidence supporting the role of DUT gene in diabetes with bone marrow failure syndrome
Ghawil, M., Abdulrahman, F., Hadeed, I., Doggah, M., Zarroug, S., & Habeb, A. M. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62771 · Cited by 6
Butnariu, L. I., Bizim, D. A., Oltean, C., Rusu, C., Pânzaru, M.-C., Păduraru, G., Gimiga, N., Ghiga, G., Moisă, Ș. M., Țarcă, E., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126318 · Cited by 6
Linee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici
Marx, N., Federici, M., Schütt, K. S., Müller‐Wieland, D., Ajjan, R., Antunes, M. J., Christodorescu, R., Crawford, C. A., Angelantonio, E. D., Eliasson, B., et al. (2024) · Giornale Ialiano di Cardiologia · doi:10.1714/4162.41558 · Cited by 6
The Role of Imatinib in Pediatric Type 1 Diabetes
Lavelle, K., Chamberlain, C. E., German, M., Anderson, M. S., Nip, A., & Gitelman, S. E. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae065 · Cited by 6
Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
Razzaghy‐Azar, M., Nourbakhsh, M., Talea, A., Amoli, M. M., Nourbakhsh, M., & Larijani, B. A. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-03052-5 · Cited by 6
A family with type A insulin resistance syndrome caused by a novel insulin receptor mutation
Horikawa, O., Ugi, S., Takayoshi, T., Omura, Y., Yonishi, M., Sato, D., Fujita, Y., Fuke, T., Hirota, Y., Ogawa, W., et al. (2023) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-22-0362 · Cited by 6
Pace, N. P., Vella, B., Craus, J., Caruana, R., Savona‐Ventura, C., & Vassallo, J. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3486 · Cited by 5
Liu, T., Alagu Sankareswaran, S., Paterson, G. G., Akhtar, S., Angel, A., Asgar, O., Ashraf, S., Bidi, S., Breen, G. D., Broster, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-80348-8 · Cited by 5
Precision Medicine in Diabetes
Dawed, A. Y., Haider, E., & Pearson, E. R. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_590 · Cited by 5
Self-citationDhayalan, B., Chen, Y., Ni, C., & Weiss, M. A. (2024) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-024-10665-z · Cited by 5
Tan, C. S. H., Kee, K. X., Zheng, H., Chan, L. W. T., Song, Y., Kon, W. Y. C., Chee, Y. J., Lian, J. X., Vasanwala, R. F., Yap, F. K. P., et al. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2024-012 · Cited by 4
Alarcon, G., Maston, G. A., Hoffman, C. A., Posey, J. E., REDONDO, M. J., & Tosur, M. (2024) · Hormone Research in Paediatrics · doi:10.1159/000539542 · Cited by 4
Pérez-López, P., Bahillo-Curieses, P., Fernández-Velasco, P., Martínez, R., Delgado, E., Ortolá, A., de Luis, D. A., & Díaz-Soto, G. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.03.006 · Cited by 4
Understanding the Mechanism of Diabetes Mellitus in a LRBA-Deficient Patient
Hawari, I., Ericsson, J., Kabeer, B. S. A., Chaussabel, D., Al-Sulaiti, A. M., Sharari, S., Maccalli, C., Khan, F. A., & Hussain, K. (2022) · Biology · doi:10.3390/biology11040612 · Cited by 4
Exploring the Role of Precision Medicine in Diabetes Diagnoses
Galloway, N., Blanchette, J. E., Faizullabhoy, A., Mobley-Bukstein, W., RINKER, J. K., & Isaacs, D. M. (2021) · ADCES in Practice · doi:10.1177/2633559x211060849 · Cited by 4
Scobie, I. N., & Hopkins, D. L. (2023) · CRC Press eBooks · doi:10.1201/9781003342700 · Cited by 4
HNF1α -Q125ter-mediated mitochondrial dysfunction and impaired mitophagy in β-cells
Jiang, F., Huang, J., Chen, X., Zhang, X., & Chen, Y.-L. (2025) · Journal of Molecular Endocrinology · doi:10.1530/jme-25-0033 · Cited by 4
Clinical profile of monogenic diabetes: A case series from a single South Indian diabetes clinic
Sureshkumar, P., Radha, V., Unnikrishnan, R., & Mohan, V. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01403-8 · Cited by 4
Hassan, S. S., Musa, S. A., Franco, E. D., Myers, R., Heugten, R. V., Babiker, O., Ibrahim, A. A., Mohamadsalih, G., Ahmed, A., Shatta, J. A., et al. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0316 · Cited by 3
Limbert, C., Lanzinger, S., de Beaufort, C. E., Iotova, V., Pélicand, J., Prieto, M., Schiaffini, R., Šumník, Z., & Pacaud, D. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110110 · Cited by 3
Reyed, R. M. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-3121-8.ch001 · Cited by 3
Precision Diagnostics for Monogenic Diabetes in Children
Ortega, H., & Gloyn, A. L. (2025) · SMART-MD journal of precision medicine. · doi:10.69734/1e8v6h36 · Cited by 3
Arosemena, M., Chopra, K., Salguero, M. V., Reyes, D., Naylor, R. N., Wroblewski, K., Tasali, E., & Philipson, L. H. (2026) · Diabetes · doi:10.2337/db24-0787 · Cited by 2
Self-citationZhang, C., & Ma, Y. (2026) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2026.109335 · Cited by 2
Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program
Chase, C. L., Accardo, M.-L., Greve, V., Ames, E. G., Quinonez, S. C., Scott, A. J., Hipp, L. E., Damon, J., Uhlmann, W. R., Broome, D. T., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf091 · Cited by 2
Watanabe, H., Goto, S., Hosojima, M., Kabasawa, H., Imai, N., Ito, Y., & Narita, I. (2023) · Human Genome Variation · doi:10.1038/s41439-023-00233-0 · Cited by 2
Pérez-López, P., Bahillo-Curieses, P., Fernández-Velasco, P., Martínez, R., Delgado, E., Ortolá, A., de Luis, D. A., & Díaz-Soto, G. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.12.008 · Cited by 2
Endocrine disorders in infants, children, and adolescents
Shi, M., & PAGE, L. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00050-9 · Cited by 2
Editorial Cycles and Continuity of Diabetes Care
Riddle, M. C., Aroda, W. A. O. B. O. A. E. V., Bakris, G. L., Blonde, L., Boulton, A. J. M., Castle, J. R., DiMeglio, L. A., Gonder-Frederick, L. A., Hu, F. B., Kahn, S. E., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0020 · Cited by 2
Self-citationSingh, K., Shivashankar, R., Gandral, M., Aravind, L. R., & Tandon, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_17 · Cited by 2
Dušátková, P., Pavlíková, M., Cermakova, M., Veselá, K., Kolářová, K., Elblová, L., Šumník, Z., Lebl, J., & Průhová, Š. (2026) · Diabetic Medicine · doi:10.1111/dme.70279 · Cited by 2
Tas, E., Al-Hosain, E., Movva, S., Colangelo, T., & Gurtünca, N. (2024) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2024.100171 · Cited by 2
Precision medicine in diabetes - current trends and future directions. Is the future now?
Szczerbiński, Ł., & Florez, J. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00021-6 · Cited by 1
Thewjitcharoen, Y., Chatchomchuan, W., Wanothayaroj, E., Nakasatien, S., Lim, C. K. P., Himathongkam, T., & Chan, J. C. N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1717121 · Cited by 1
Development of a Calculator for HNF1A- and HNF4A-MODY in Asian Indians
Mohan, V., Venkatesan, U., Amutha, A., Aarthy, R., Radha, V., Pande, A. R., Anjana, R. M., & Unnikrishnan, R. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261429944 · Cited by 1
Exploring the genetic basis of childhood monogenic diabetes
Sanyal, D. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i9.1829 · Cited by 1
Permanent Neonatal Diabetes Mellitus
Senarathne, U. D., Franco, E. D., Abdelmeguid, Y., Lu, Z. X., & Brown, J. J. (2023) · Springer eBooks · doi:10.1007/978-3-319-66816-1_1845-1 · Cited by 1
As, A., Galstyan, G. R., Dudina, M., Erina, E. E., Servier JSC, M., Киселева, Т. А., Klimontov, V. V., Кононенко, И. В., & Васильевна, Ц. О. (2024) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2024-13-4-06-16 · Cited by 1
Monogenic Diabetes: Genetic Insight and Precision Therapeutics in the Management of MODY
Venkatesan, G., Kumari, K. V., Ariya, S. S., & Vijayababu, P. (2025) · Exon. · doi:10.69936/en02y0025 · Cited by 1
Monogenic Diabetes: Genotype, Clinical Phenotype, and Treatment: A Narrative Review
Al-Malki, S. (2024) · Journal of Healthcare Sciences · doi:10.52533/johs.2024.41216 · Cited by 1
Ujong, G. O., Beshel, J. A., Okon, I. A., & Owu, D. U. (2022) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2022.11.1.0109 · Cited by 1
Mozzillo, E., Maltoni, G., Chiavaroli, V., Dovč, K., & Marigliano, M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.786055
Dhayalan, B., Chen, Y., Yang, Y., Jarosinski, M. A., Chatterjee, D., Grabowski, R., Poordian, S., Phillips, N. F. B., Arvan, P., Ismail‐Beigi, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.24.461687
Recessive Genome-wide Meta-analysis Illuminates Genetic Architecture of Type 2 Diabetes
O’Connor, M. J., Schroeder, P. H., Huerta‐Chagoya, A., Cortés-Sánchez, P., Bonàs‐Guarch, S., Guindo-Martínez, M., Cole, J. B., Kaur, V., Torrents, D., Veerapen, K., et al. (2021) · doi:10.2337/figshare.17099780.v1
Monogenic Diabetes, Case Series from Four Arab Countries
Eltonbary, K. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.180958
Metadata
- Authors
- Riddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T.
- Affiliations
- Oregon Health & Science University (US)
- University of Chicago (US)
- University of Virginia (US)
- Lund University (SE)
- Harvard University (US)
- Trinity College Dublin (IE)
- University of Dundee (GB)
- Children's Hospital Colorado (US)
- University of Exeter (GB)
- Corresponding author
- Riddle, Matthew C.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-11-12
- Volume
- 43
- Issue
- 12
- Pages
- 3117-3128
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8162450
- OpenAlex
- W3106034474
- Cited by
- 117
- References
- 103
- Citations by year
- 2026: 24 · 2025: 9 · 2024: 21 · 2023: 23 · 2022: 23 · 2021: 16 · 2020: 1
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Wellcome Trust (102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219)
- Novo Nordisk Fonden (NNF18OC0034050, NNF14OC0011039, NNF17OC0026828)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK104942, P30DK020595)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- monogenic diabetes, precision medicine, genetic diagnosis, disease heterogeneity, screening, diagnosis, diabetes management, pathophysiology, genetic mutations, expert consensus
- MeSH terms
- Congresses as Topic, Diabetes Mellitus, Endocrinology, Expert Testimony, Humans, Patient-Centered Care, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.